KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Gains from Investment Securities (2016 - 2025)

Cardinal Health's Gains from Investment Securities history spans 17 years, with the latest figure at -$10.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 233.33% year-over-year to -$10.0 million; the TTM value through Dec 2025 reached -$8.0 million, down 100.0%, while the annual FY2024 figure was -$2.0 million, 101.28% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$10.0 million at Cardinal Health, down from $5.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $273.0 million in Q2 2021 and bottomed at -$10.0 million in Q4 2025.
  • The 5-year median for Gains from Investment Securities is $1.0 million (2021), against an average of $46.9 million.
  • The largest YoY upside for Gains from Investment Securities was 400.0% in 2025 against a maximum downside of 233.33% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then skyrocketed by 15500.0% to $156.0 million in 2023, then plummeted by 101.92% to -$3.0 million in 2024, then tumbled by 233.33% to -$10.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Gains from Investment Securities are -$10.0 million (Q4 2025), $5.0 million (Q3 2025), and -$3.0 million (Q4 2024).